This information was published on 2024-12-31T00:06:16 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2474213 (IR 1583980) |
| (220) |
30 Jul 2024
|
| (511) (510) |
Class 5
Immunoglobulin for intramuscular and intravenous administration to humans. |
| (540) | GAMMAGARD |
| (550) | Word |
| (730) |
BAXALTA INCORPORATED
|
Find out more about publications on the About page.